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INTRODUCTION 
HL-60 cells, a human promyelocytic leukemic cell line, grow in suspension, 
but when induced to differentiate along the monocyte pathway they adhere to 
tissue culture plates and undergo morphological changes. In contrast, when 
HL-60 cells are induced to differentiate along the granulocyte pathway cells remain 
in suspension. There is increasing evidence that adhesion molecules and their 
associated receptors play a key role in regulating numerous biological and patholog- 
ical events, including cell differentiati~n.~ Adhesion molecules either increase or 
decrease depending on cell type during, or as a result of, differentiati~n.~-' Also, 
they and their associated cell surface receptors are expressed in a unique fashion 
during development, both temporally and spatially, suggesting a role for such 
molecules in cell although the precise roles for adhesion mole- 
cules in these events remain to be determined. We hypothesized that differentiation 
of HL-60 cells along the monocytelmacrophage pathway is related to increased 
expression of specific adhesion molecules and integrin receptors. Furthermore, 
such adhesion molecules would not be regulated in the same fashion during differ- 
entiation along the granulocyte pathway. 
METHODS 
HL-60 cells obtained from ATCC were maintained in RPMI, and media of test 
cultures were treated with phorbol 12-myristate 13-acetate (PMA), a monocyte- 
inducing agent, at a concentration of 1.5 nM in ethanol, retinoic acid (RA), a 
granulocyte-inducing agent, at a concentration of M in ethanol, or an equiva- 
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lent amount of ethanol alone. Flasks were harvested at 6, 24, 48, and 72 hours 
after treatment, and RNA was isolated. 
For Northern analysis, total RNA (30 pg/lane) was denatured and electro- 
phoresed on a 1.2% agarose gel containing 18% of a 37% formaldehyde solution. 
RNA was transferred to a nylon membrane and UV cross-linked. The membrane 
was probed sequentially with a3*-P dCTP-labeled cDNAs specific for a ,  integrin, 
osteopontin (OPN) and 18S/28S RNA. 
ELISA analysis was performed using partially purified monoclonal antibodies 
to osteoclast-specific cell surface markers 121F and 75B. ELISA values were 
normalized for total sample protein. 
RESULTS 
Cells exposed to PMA showed a dramatic change in morphology, associated 
with adhesion, when compared to cells treated with RA or vehicle. As seen in 
TABLE 1 ,  nearly 100% of PMA-treated cells were attached to flasks by 24 hr of 
treatment, while cells treated with vehicle or RA continued to grow in suspension 
over time. 
Northern analysis showed an induction of OPN mRNA with as little as 6 hr 
of PMA treatment. OPN levels peaked at 24 hr of treatment, and levels remained 
high for further time points. Levels of a ,  mRNA also increased with PMA treat- 
ment, but this increase occurred more slowly with continued increase in expression 
up to 72 hr. This result contrasted with Northern analysis of control and RA- 
treated cells (FIG. I ) ,  where no OPN or a ,  mRNA could be detected after 48 hr 
of treatment. 
Induction of 121F and 75B, osteoclast-specific cell-surface antigens, with PMA 
treatment paralleled increases in mRNA levels of OPN and a,. 
CONCLUSIONS 
OPN levels peak at approximately 24 hr following induction of differentiation 
along the monocyte/macrophage pathway. In contrast, levels of a ,  integrin in- 
crease more gradually. Differentiation along the granulocyte pathway resulted in 
no apparent induction of OPN or a,,  and cells did not adhere to flasks. An increase 
in osteoclast-specific cell-surface antigens accompanied adhesion molecule in- 
duction. 
TABLE 1. Effects of Agents on Cell Attachment In  Vitro" 
% Adherent Cells 
Treatment 6 Hr 24 Hr 48 Hr 72 Hr 
Control 0 0 0 0 
RA 0 0 0 0 
PMA 0 75 90 93 
Cells were plated at a concentration of 2 x los cells/ml, and treated with retinoic acid 
M ,  12-myristate 13-acetate (PMA), 1.5 nM or ethanol (control) and percent of (RA), 
cells attached versus suspended determined at designated times by Coulter Counter. 
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FIGURE 1. Effect of experimental treatments on mRNA levels of a, and OPN in HL-60 
cells. Northern hybridization of RNA from cells treated with retinoic acid or PMA. The 
j r s r  lane shows mRNA levels with PMA treatment for 48 hr, which is compared with control 
and 48-hr treatment with 1% DMSO, M retinoic acid, or lo-' M retinoic acid + 
1% DMSO. 
These findings indicate an association between the adhesion of differentiated 
HL-60 cells to tissue culture dishes and expression of integrins and OPN, an 
adhesion molecule considered to be instrumental in regulation of differentiation 
and function of many cell types, including osteoclasts." 
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